Based on our findings that MSLN promotes BM by encouraging NSCLC cells to cross the BBB, a key rate-limiting link, targeting MSLN is expected to be a therapeutic strategy for preventing BM in NSCLC. The gene discussed is MSLN; the disease is non-small cell lung carcinoma.